---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-092550"
form_type: "8-K"
ticker: null
cik: "0000861838"
company_name: "Aceragen, Inc."
filed_at: "2023-08-16T23:59:59+00:00"
generated_at: "2026-06-11T09:01:33.818536+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Aceragen liquidates via assignment for benefit of creditors; board and CEO resign; delisting

## Summary
- Stockholders approved assignment for benefit of creditors; company transfers all assets to ACG (ABC), LLC, effective Aug 16.
- Entire Board (Cristina Csimma, Michael Dougherty, Maxine Gowen, Vincent Milano, Ron Wooten) resigns effective Aug 15/16.
- CEO John Taylor terminated; enters separation agreement with $100k success fee for consulting on asset liquidation.
- Company to voluntarily delist from Nasdaq (Form 25 filed Aug 15) and terminate SEC reporting.
- NovaQuest holds first-priority lien; proceeds distributed per Collateral Agreement.

## SEC filing metadata
- accession: 0001104659-23-092550
- form_type: 8-K
- cik: 0000861838
- company_name: Aceragen, Inc.
- filed_at: 2023-08-16T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/861838/000110465923092550/0001104659-23-092550-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/861838/000110465923092550/tm2323610d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-092550
- JSON: https://secwatch.observer/filing/0001104659-23-092550.json
- Plain text: https://secwatch.observer/filing/0001104659-23-092550.txt

## Key facts
- Executive change
  Cristina Csimma resigned as Director at Aceragen, Inc..
  - Action: resigned
  - Role: Director
  source text: On August 15, 2023, Cristina Csimma, Michael Dougherty, Maxine Gowen, Vincent Milano and Ron Wooten, members of the Board of Directors (the “Board”) of Aceragen, Inc. (the “Company”), each provided notice of their decision to resign from the Board effective contemporaneous with the execution of the Assignment Agreement
  evidence_url: https://www.sec.gov/Archives/edgar/data/861838/000110465923092550/0001104659-23-092550-index.htm
- Executive change
  Michael Dougherty resigned as Director at Aceragen, Inc..
  - Action: resigned
  - Role: Director
  source text: On August 15, 2023, Cristina Csimma, Michael Dougherty, Maxine Gowen, Vincent Milano and Ron Wooten, members of the Board of Directors (the “Board”) of Aceragen, Inc. (the “Company”), each provided notice of their decision to resign from the Board effective contemporaneous with the execution of the Assignment Agreement
  evidence_url: https://www.sec.gov/Archives/edgar/data/861838/000110465923092550/0001104659-23-092550-index.htm
- Executive change
  Maxine Gowen resigned as Director at Aceragen, Inc..
  - Action: resigned
  - Role: Director
  source text: On August 15, 2023, Cristina Csimma, Michael Dougherty, Maxine Gowen, Vincent Milano and Ron Wooten, members of the Board of Directors (the “Board”) of Aceragen, Inc. (the “Company”), each provided notice of their decision to resign from the Board effective contemporaneous with the execution of the Assignment Agreement
  evidence_url: https://www.sec.gov/Archives/edgar/data/861838/000110465923092550/0001104659-23-092550-index.htm
- Executive change
  John Taylor was terminated as President, Chief Executive Officer, Chief Financial Officer at Aceragen, Inc..
  - Action: terminated
  - Role: President, Chief Executive Officer, Chief Financial Officer
  source text: Also on August 15, 2023, the Company and John Taylor, the Company’s President, Chief Executive Officer, Chief Financial Officer and member of the Board, entered into that certain Executive Separation Agreement (the “Separation Agreement”), pursuant to which, in connection and contemporaneous with the Company’s entry into the Assignment Agreement and effectuation of the Assignment pursuant thereto, Mr. Taylor’s employment with the Company terminated.
  evidence_url: https://www.sec.gov/Archives/edgar/data/861838/000110465923092550/0001104659-23-092550-index.htm
- Executive change
  Ron Wooten resigned as Director at Aceragen, Inc..
  - Action: resigned
  - Role: Director
  source text: On August 15, 2023, Cristina Csimma, Michael Dougherty, Maxine Gowen, Vincent Milano and Ron Wooten, members of the Board of Directors (the “Board”) of Aceragen, Inc. (the “Company”), each provided notice of their decision to resign from the Board effective contemporaneous with the execution of the Assignment Agreement
  evidence_url: https://www.sec.gov/Archives/edgar/data/861838/000110465923092550/0001104659-23-092550-index.htm
- Executive change
  Vincent Milano resigned as Director at Aceragen, Inc..
  - Action: resigned
  - Role: Director
  source text: On August 15, 2023, Cristina Csimma, Michael Dougherty, Maxine Gowen, Vincent Milano and Ron Wooten, members of the Board of Directors (the “Board”) of Aceragen, Inc. (the “Company”), each provided notice of their decision to resign from the Board effective contemporaneous with the execution of the Assignment Agreement
  evidence_url: https://www.sec.gov/Archives/edgar/data/861838/000110465923092550/0001104659-23-092550-index.htm
- Shareholder Votes
  Aceragen, Inc. shareholders approved Approve assignment for the benefit of creditors at the 2023-08-14 meeting.
  - Outcome: passed
  - Meeting: 2023-08-14
  source text: The stockholders approved the Assignment Proposal, with votes as follows: Shares For Shares Against Shares Abstained Broker Non-Votes 4,993,040 54,342 3,640 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/861838/000110465923092550/0001104659-23-092550-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.